|
DK319780A
(da)
*
|
1980-07-24 |
1982-01-25 |
Forenede Bryggerier As |
Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
|
|
DK353781A
(da)
*
|
1981-08-10 |
1983-02-11 |
Novo Industri As |
Fremgangsmaade til fremstilling af insulinderivater
|
|
CA1174623A
(en)
*
|
1981-09-15 |
1984-09-18 |
Finn H. Andresen |
Process for preparing human insulin or b-30 esters thereof
|
|
NL8201650A
(nl)
*
|
1982-04-21 |
1983-11-16 |
Akzo Nv |
Semisynthetische bereiding van humane insuline.
|
|
US4528134A
(en)
*
|
1982-12-27 |
1985-07-09 |
University Of Tn Research Corporation |
Method of separating A14 -125 I-insulin from heterogeneously labeled insulin molecules for biological studies
|
|
DK58285D0
(da)
*
|
1984-05-30 |
1985-02-08 |
Novo Industri As |
Peptider samt fremstilling og anvendelse deraf
|
|
PH25772A
(en)
*
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
DK257988D0
(da)
*
|
1988-05-11 |
1988-05-11 |
Novo Industri As |
Nye peptider
|
|
DE3844211A1
(de)
*
|
1988-12-29 |
1990-07-05 |
Hoechst Ag |
Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
DK134189D0
(da)
*
|
1989-03-20 |
1989-03-20 |
Nordisk Gentofte |
Insulinforbindelser
|
|
US5512459A
(en)
*
|
1993-07-20 |
1996-04-30 |
Bionebraska, Inc. |
Enzymatic method for modification or recombinant polypeptides
|
|
EA200000453A1
(ru)
|
1997-10-24 |
2000-10-30 |
Эли Лилли Энд Компани |
Композиции нерастворимого инсулина
|
|
CO4970787A1
(es)
*
|
1997-12-23 |
2000-11-07 |
Lilly Co Eli |
Composiciones insolubles de insulina y derivados de insulina que controlan la glucosa sanguinea
|
|
BR0016860A
(pt)
|
1999-12-29 |
2002-10-01 |
Novo Nordisk As |
Precursor da insulina ou análogo de precursor de insulina, sequência de polinucleotìdeo, vetor de expressão, célula hospedeira, e, processos para fabricar um precursor da insulina ou análogo de precursor de insulina, e, insulina ou um análogo de insulina
|
|
AR025646A1
(es)
*
|
2000-09-13 |
2002-12-04 |
Beta Lab Sa |
Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
|
|
US7396903B2
(en)
*
|
2001-11-19 |
2008-07-08 |
Novo Nordisk A/S |
Process for preparing insulin compounds
|
|
AU2002342597A1
(en)
|
2001-11-19 |
2003-06-10 |
Novo Nordisk A/S |
Process for preparing insulin compounds
|
|
UA46667C2
(en)
*
|
2001-12-29 |
2006-01-16 |
Omakooe Ltd Liability Company |
Method for preparing semisynthetic human insulin
|
|
DE602005014962D1
(de)
*
|
2004-03-12 |
2009-07-30 |
Biodel Inc |
Insulinzusammensetzungen mit verbesserter wirkstoffabsorption
|
|
US20080096800A1
(en)
*
|
2004-03-12 |
2008-04-24 |
Biodel, Inc. |
Rapid mucosal gel or film insulin compositions
|
|
US20080085298A1
(en)
*
|
2004-03-12 |
2008-04-10 |
Biodel, Inc. |
Rapid Mucosal Gel or Film Insulin Compositions
|
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
|
CN101166545B
(zh)
|
2005-05-13 |
2011-06-15 |
伊莱利利公司 |
Glp-1聚乙二醇化的化合物
|
|
BRPI0520362B1
(pt)
*
|
2005-07-08 |
2017-10-17 |
Biocon Limited |
Preparation of insulin conjugates
|
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
US7713929B2
(en)
*
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
|
WO2007121256A2
(en)
*
|
2006-04-12 |
2007-10-25 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
|
MX2008013304A
(es)
|
2006-04-20 |
2008-10-27 |
Amgen Inc |
Compuestos de peptido 1 tipo glucagon.
|
|
CA2711561A1
(en)
*
|
2008-01-04 |
2009-07-16 |
Biodel, Inc. |
Insulin formulations for insulin release as a function of tissue glucose levels
|
|
JP5698977B2
(ja)
|
2008-07-30 |
2015-04-08 |
武田薬品工業株式会社 |
メタスチン誘導体およびその用途
|
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
|
WO2011031662A1
(en)
|
2009-09-08 |
2011-03-17 |
Kent Stephen B H |
Ester insulin
|
|
JP5973427B2
(ja)
|
2010-06-23 |
2016-08-23 |
ノヴォ ノルディスク アー／エス |
追加のジスルフィド結合を含有するインスリン類似体
|
|
CN102933599A
(zh)
|
2010-06-23 |
2013-02-13 |
诺沃—诺迪斯克有限公司 |
包含额外的二硫键的人胰岛素
|
|
WO2011161125A1
(en)
|
2010-06-23 |
2011-12-29 |
Novo Nordisk A/S |
Insulin derivatives containing additional disulfide bonds
|
|
JP2014509603A
(ja)
|
2011-03-15 |
2014-04-21 |
ノヴォ ノルディスク アー／エス |
システイン置換を含むヒトインスリン類似体およびヒトインスリン誘導体
|
|
US9260503B2
(en)
|
2011-06-15 |
2016-02-16 |
Novo Nordisk A/S |
Multi-substituted insulins
|
|
CA2890048C
(en)
|
2012-12-03 |
2022-05-03 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
|
|
US20160115216A1
(en)
|
2013-06-07 |
2016-04-28 |
Novo Nordisk A/S |
Method for Making Mature Insulin Polypeptides
|
|
UA119762C2
(uk)
*
|
2013-12-23 |
2019-08-12 |
Біокон Ресерч Лімітед |
Спосіб отримання метилового ефіру інсуліну людини
|
|
AU2018317810A1
(en)
|
2017-08-17 |
2020-03-19 |
Novo Nordisk A/S |
Novel acylated insulin analogues and uses thereof
|
|
WO2023144240A1
(en)
|
2022-01-26 |
2023-08-03 |
Novo Nordisk Research Centre Oxford Limited |
Glucose sensitive insulin derivatives and uses thereof
|